Free Trial

UnitedHealth Group Incorporated $UNH Holdings Trimmed by NBC Securities Inc.

UnitedHealth Group logo with Medical background

NBC Securities Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,273 shares of the healthcare conglomerate's stock after selling 1,562 shares during the period. NBC Securities Inc.'s holdings in UnitedHealth Group were worth $1,957,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management purchased a new stake in UnitedHealth Group in the 4th quarter worth about $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth about $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in UnitedHealth Group in the 4th quarter worth about $44,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $348.05 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $315.22 billion, a PE ratio of 15.08, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The business has a 50 day simple moving average of $292.87 and a 200 day simple moving average of $367.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group's payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on UNH shares. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Wells Fargo & Company dropped their target price on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $358.95.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines